Zenas Biopharma Inc (ZBIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access ZBIO quarterly Balance Sheets →
The data below summarizes Zenas Biopharma Inc's balance sheet position from to Dec 31 2025, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent110.64
Short-term Investments, Total232.55
Cash & Short-term Investments342.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.98
Total Current Assets351.17
Equipment/Property/Plant Net0.03
Long-term investments17.27
Other Assets, Noncurrent32.44
Restricted Cash Current-
Operating Lease Right Of Use Asset1.35
Total Assets383.64
Liabilities
Accounts Payable, Current AC7.11
Accrued Liabilities, Current AC54.42
Other Liabilities, Current1.12
Total Current Liabilities62.65
Long-term debt78.64
Total Long-term Debt78.64
Other liabilities, Noncurrent0.21
Operating Lease Liability Current1.12
Operating Lease Liability Noncurrent0.21
Total Liabilities141.50
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,007.33
Retained Earnings / Accumulated Deficit-765.13
Other Equity-0.06
Common Stockholder's Equity242.14
Total Stockholder's Equity242.14
Liabilities & Stockholder's Equity383.64
4 historic quarters locked

Sign in to unlock the full Zenas Biopharma Inc balance sheet history.

About Zenas Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-027964

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License